Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells

Neoplasma

Volumn 52, Issue 4, 2005, Pages 352-359

  Sarissky M ^a   Lavicka J ^a   Kocanova S ^a   Sulla I ^b   Mirossay A ^a   Miskovsky P ^a   Gajdos M ^b   Mojzis J ^a   Mirossay, L ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

Apoptosis; Diazepam; Glioma; Hypericin; Peripheral benzodiazepine receptor; Photodynamic therapy

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM; HYPERICIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MALE; PHOTOACTIVATION; PHOTODYNAMIC THERAPY;

EID: 23044504472     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. AGOSTINIS P, VANTIEGHEM A, MERLEVEDE W, DE WITTE PA. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002; 34: 221-241.
2. ALI SM, CHEE SK, YUEN GY, OLIVO M. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells. Int J Mol Med 2002; 9: 601-616.
3. ALI SM, CHEE SK, YUEN GY, OLIVO M. Hypocrellins and Hypericin induced apoptosis in human tumor cells: a possible role of hydrogen peroxide. Int J Mol Med 2002; 9: 461-472.
4. BANKER DE, COOPER JJ, FENNELL DA, WILLMAN CL, APPELBAUM FR et al. PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leuk Res 2002; 26: 91-106.
5. BRAESTRUP C, SQUIRES RF. Specific benzodiazepine receptors in rat brain characterized by high affinity [3H]diazepam binding. Proc Natl Acad Sci USA 1977; 74: 1839-1847.
6. CARAYON P, DUSSOSSOY D, CANAT X, CASELLAS P. Quantification et localisation des récepteurs péripheriques des benzodiazé pines. In: Métézeau P, Ratinaud M-H, Carayon P, editors. Cytométrie par Fluorescence. Apports Comparatifs des Techniques Flux, Image et Confocale. Paris: Éditions INSERM, 1994: 151-169.
7. CHALOUPKA R, PETIT PX, ISRAEL N, SUREAU F. Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway. FEBS Lett 1999; 462: 295-301.
8. CHEN B, ROSKAMS T, XU Y, AGOSTINIS P, DE WITTE PA. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int J Cancer 2002; 98: 284-290.
9. CORNU P, BENAVIDES J, SCATTON B, HAUW JJ, PHILIPPON J. Increase in 3 (peripheral-type benzodiazepine) binding site densities in differential types of human brian tumours. Acta Neurochir 1992; 119: 146-152.
10. COULDWELL WT, GOPALAKRISHNA R, HINTON DR, HE S, WEISS MH et al. Hypericin: a potent antiglioma therapy. Neurosurgery 1994; 35: 705-710.
11. DECAUDIN D, CASTEDO M, NEMATI F, BEURDELEY-THOMAS A, DE PINIEUX G et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res 2002; 62: 1388-1393.
12. DIAMOND I, GRANELLI SG, MCDONAGH AF, NIELSEN S, WILSON CB et al. Photodynamic therapy of malignant tumours. Lancet 1972; 2: 1175-1177.
13. FENNEL DA, CORBO M, PALLASKA A, COTTER FE. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br J Cancer 2001; 84: 1397-1404.
14. FERRARESE C, APPOLLONIO I, FRIGO M, GAINI SM, PIOLTI R et al. Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumours. Ann Neurol 1989; 26: 564-568.
15. FOX E, MURPHY RF, MCCULLY CL, ADAMSON PC. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates. Cancer Chemother Pharmacol 2001; 47: 41-44.
16. HIRSCH T, DECAUDIN D, SUSIN SA, MARCHETTI P, LAROCHETTE N et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998; 241: 426-434.
17. HUNCHAREK M, MUSCAT J. Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res 1998; 18: 1303-1311.
18. KESSEL D, ANTOLOVICH M, SMITH KM. The role of peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. Photochem Photobiol 2001; 74: 346-349.
19. KLEIHUES P, CAVENEE WK, editors. World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000.
20. KLEIHUES P, LOUIS DN, SCHEITHAUER BW, RORKE LB, REIFENBERGER G et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225.
21. KOMAROV PG, KOMAROVA EA, KONDRATOV RV, CHRISTOV-TSELKOV K, COON JS et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285: 1733-1737.
22. LAVIČKA J, ŠARIŠSKY M, MIROŠŠAY A, ŠULLA I, MOJŽIŠ J et al. Diazepam enhances etoposide-induced cytotoxicity in U-87 MG human glioma cell line. Fundam Clin Pharmacol 2001; 15: 201-207.
23. MAASER K, HOPFNER M, JANSEN A, WEISINGER G, GAVISH M et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 2001; 85: 1771-1780.
24. MICCOLI L, BEURDELEY-THOMAS A, DE PINIEUX G, SUREAU F, OUDARD S et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 1998; 15: 5777-5786.
25. MICCOLI L, POIRSON-BICHAT F, SUREAU F, BRAS GONCAVALES R, BOURGEOIS Y et al. Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment. J Natl Cancer Inst 1998; 90: 1400-1406.
26. MIETTINEN H, KONONEN J, HAAPASALO H, HELEN P, SALLINEN P et al. Expression of peripheral-type benzodiazepine receptor and diazepam-binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 1995; 55: 2691-2695.
27. MIŠKOVSKY̌ P. Hypericin - a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolekules. Current Drug Targets 2002; 3: 55-84.
28. MORGAN J, HANLEY J, OSEROFF A. PK11195 mediates enhanced phototoxicity by increasing mitochondrial uptake of photosensitizer via the peripheral benzodiazepine receptor. 29th Annual Meeting of the American Society of Photobiology, Downtown Marriot, Chicago, Illinois, USA, July 7-12 2001.
29. MOSMANN T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
30. OUDARD S, CARPENTIER A, BANU E, FAUCHON F, CELERIER D et al. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol 2003; 63: 81-86.
31. PASTORINO JG, SIMBULA G, YAMAMOTO K, GLASCOTT PA JR, ROTHMAN RJ et al. The cytotoxicity of tumor necrosis factor depends in induction of the mitochondrial permeability transition. J Biol Chem 1996; 271: 29792-29798.
32. PERRIA C, CAPUZZO T, CAVAGNARO G, DATTI R, FRANCAVIGLIA N et al. Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 1980; 24: 119-29.
33. POPOVIC EA, KAYE AH, HILL JS. Photodynamic therapy of brain tumors. J Clin Laser Med Surg 1996; 14: 251-261.
34. RADHAKRISHNAN K, MOKRI B, PARISI JE, O'FALLON WM, SUNKU J et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995; 37: 67-73.
35. SCHEMPP CM, SIMON-HAARHUS B, TERMEER CC, SIMON JC. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett 2001; 493: 26-30.
36. TAFT WC, DELORENZO RJ. Micromolar-affmity benzodiazepine receptor regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci 1984; 81: 3118-3122.
37. THOMAS C, MACGILL RS, MILLER GC, PARDINI RS. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobiol 1992; 55: 47-53.
38. UZDENSKY AB, MA L-W, IANI V, HJORTLAND GO, STEEN HB et al. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers Med Sci 2001; 16: 276-283.
39. VANTIEGHEM A, ASSEFA Z, VANDENABEELE P, DECLERCQ W, COURTOIS S et al. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 1998; 440: 19-24.
40. VERMA A, FACCHINA SL, HIRSCH DJ, SONG S-Y, DILLAHEY LF et al. Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target. Mol Med 1998; 4: 40-45.
41. WELLER M, TREPEL M, GRIMMEL C, SCHABET M, BREMEN D et al. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 1997; 19: 459-470.